News | March 03, 2022
Merck KGaA reports higher profits on strong volumes across its businesses
Company expects strong organic growth in sales, EBITDA in 2022
Company expects strong organic growth in sales, EBITDA in 2022
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
The product will be manufactured at Lupin’s facility in Pithampur, India
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs
Subscribe To Our Newsletter & Stay Updated
